Note 10. Subsequent Events

In preparing these financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through the filing of this Quarterly Report on Form 10-Q. The following subsequent events were identified for disclosure:

Share Issuance

As of July 1, 2026, the Company sold 194,814 Shares at a price of $34.61 per Share (with the final number of Shares being determined on July 15, 2026) to accredited investors in a private placement of Shares for an aggregate purchase price of $6,742,500.

Distributions

On July 15, 2026, the Company paid the distribution of $0.0162 per share to shareholders of record as of June 30, 2026, for a total amount of $79,656.

Investments

On July 31, 2026, the Company invested $2.0 million into an unsecured convertible note of Kythera Labs, Inc. The note has an interest rate of 12% and matures on October 31, 2027.

Share Repurchase Program

On July 20, 2026, the Company commenced a tender offer under Rule 13e-4 to repurchase up to 245,851 Shares at a price equal to NAV per Share as of September 30, 2026. The offer is scheduled to expire on August 14, 2026, unless extended. The Company intends to fund any repurchases with cash on hand, and any Shares repurchased will be recorded as a reduction to net assets at the time of purchase. Because settlement will occur after the end of the reporting period, the transaction is not reflected in these financial statements. See the Company's Schedule TO filed July 20, 2026 for the complete terms of the offer.